Intracardiac thrombus formation in cardiac impairment: The role of anticoagulant therapy

Postgraduate Medical Journal

Volumn 72, Issue 854, 1996, Pages 731-738

  Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Anticoagulant therapy; Cardiac impairment; Thrombus formation

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ANTICOAGULANT THERAPY; HEART FAILURE; HUMAN; INTRACARDIAC THROMBOSIS; ISCHEMIC HEART DISEASE; REVIEW; THROMBOGENESIS; THROMBOSIS PREVENTION;

EID: 0030452708     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.72.854.731     Document Type: Review

References (55)

1. Nixon JV. Left ventricular mural thrombus. Arch Intern Med 1983; 143: 1567-71.
2. Griffith GC, Stragnell R, Levinson DC, Moore FJ, Ware AG. Study of beneficial effects of anticoagulant therapy in congestive heart failure. Ann Intern Med 1952; 37: 867-87.
3. Lapeyre AC, Steele PM, Kazmier FJ, Vlietstra RE, Fuster V. Systemic embolism in chronic left ventricular aneurysm: incidence and the role of anticoagulation. J Am Coll Cardiol 1985; 6: 534-8.
4. Mullen DC, Posey L, Gabriel R, Singh HM, Flemma RJ, Lepley D. Prognostic considerations in the management of left ventricular aneurysms. Ann Thorac Surg 1977; 23: 455-60.
5. Schlichter J, Hellerstein HK, Katz LN. Aneurysm of the heart: a correlative study of one hundred and two proved cases. Medicine (Baltimore) 1954; 33: 43-86.
6. Baker DW, Wright RF. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction. JAMA 1994; 272: 1614-8.
7. Furlan AJ, Cracium AR, Raju NR, Hart N. Cerebrovascular complication associated with idiopathic hypertrophic subaortic stenosis. Stroke 1984; 15: 282-4.
8. Hardarson T, DeLaCalzada CS, Curiel R, Goodwin JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973; 2: 1462-7.
9. Gottdiener JS, Gay JA, Van-Voorhees LL, DiBianco R, Fletcher RD. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography. Am J Cardiol 1983; 52: 1281-5.
10. Falk RH, Foster E, Coats MH. Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective followup study. Am Heart J 1992; 123: 136-42.
11. Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolism. Ann Intern Med 1986; 104: 689-98.
12. Maze SS, Kotler MN, Parry WR. Flow characteristics in the dilated left ventricle with thrombus: qualitative and quantitative Doppler analysis. J Am Coll Cardiol 1989; 13: 873-81.
13. Delemarre BJ, Visser CA, Bot H, Dunning AJ. Prediction of apical thrombus formation in acute myocardial infarction based on left ventricular spatial flow pattern. J Am Coll Cardiol 1990; 15: 355-60.
14. Kessler KM. Predictors of left ventricular thrombus formation: flow, asynergy and morphology. J Am Coll Cardiol 1990; 15: 361-2.
15. Haughland JM, Asinger RW, Mikell FL, Elsperger J, Hodges M. Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation 1984; 70: 588-98.
16. Stratton JR, Nemanich JW, Johannessen KA, Resnick AD. Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy. Circulation 1988; 78: 1388-93.
17. 111In platelet imaging of left ventricular thrombi: predictive value for systemic emboli. Circulation 1990; 81: 1182-9.
18. Lip GYH, Lowe GDO, Metcalfe MJ, Rumley A, Dunn FG. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol 1995; 76: 453-8.
19. Lip GYH, Lowe GDO. Fibrin D-dimer. a useful marker of thrombogenesis? Clin Sci 1995; 89: 205-14.
20. Lip GYH, Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995; 74: 580-3.
21. Lip GYH, Lowe GDO, Metcalfe MJ, Rumley A, Dunn FG. Is diastolic dysfunction associated with thrombogenesis ? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Im J Cardiol 1995; 50: 31-42.
22. Jafri SM, Ozawa T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993; 14: 205-12.
23. Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E, Oakley CM, Cleland JG. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am Heart J 1994; 127: 607-12.
24. Yamamoto K, Ikeda U, Furuhashi K, et al. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1995; 25: 1634-10.
25. Lip GYH, Lowe GDO, Rumley A, Dunn FG. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin therapy. Br Hearty 1995; 73: 527-33.
26. Petersen P, Kastrup J, Wilhelmsen R, Schutten HJ. Atrial natriuretic peptide in atrial fibrillation before and after electrical cardioversion therapy. EILT Heart J 1988; 9: 639-41.
27. Cregler LL, Antithrombotic therapy in left ventricular thrombosis and systemic embolism. Am Heart J 1991; 123: 1110-4.
28. Ezekowitz MD, Wilson DA, Smith EO, et al. Comparasion of indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med 1982; 306: 1509-13.
29. Stratton JR, Lighty GW, Pearlman AS, Ritchie J. Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity and causes of uncertainty. Circulation 1982; 66: 156-66.
30. Visser CA, Kan G, David GK, Lie KI, Durrer D. Two dimensional echocardiography in the diagnosis of left ventricular thrombus: a prospective study of 67 patients with anatomic validation. Chest 1983; 83: 228-32.
31. Asinger RW, Mikell FL, Sharma B, Hodges M. Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. Am J Cardiol 1981; 47: 145- 56.
32. Iga K, Matsuo M, Tsuji A, et al. [Usefulness of magnetic resonance imaging (MRI) in evaluation of left ventricular apical aneurysrn] Kokyu To Junkan 1992; 40: 593-7.
33. Kessler C, Henningsen H, Reuther R, Kinnig B, Rösch M. Identification of intracardiac thrombi in stroke patients with indium-111 platelet scintigraphy. Stroke 1987; 18: 63-7.
34. 111In platelet scintigraphy and risk stratification for embolization from chronic left ventricular thrombi. Circulation 1990; 81: 1419-21.
35. Reeder GS, Lengyel M, Tajik AJ, Seward JB, Smith HC, Danielson GK. Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization. Mayo Clin Proc 1981; 56: 77-81.
36. Higgins CB, Byrd BF, McNamara MT, et al. Magnetic resonance imaging of the heart: a review of the experience in 172 subjects. Radiology 1985; 155: 671-9.
37. Nair CK, Sketch MH, Mahoney PD, Lynch JD, Mooss AN, Kenney NP. Detection of left ventricular thrombi by computerised tomography. Br Heart J 1981; 45: 535-41.
38. Weinreich DJ, Burke JF, Pauletto FJ. Left ventricular mural thrombi complicating acute myocardial infarction: long term follow-up with serial echocardiography. Ann Intern Med 1984; 100: 789-94.
39. Rearing EC, Gross SA, Schlamowitz RA, et al. Mural thrombi in myocardial infarctions. Am J Med 1983; 74: 989-95.
40. Turpie AGG, Robinson JG, Doyle DJ, et al. Prevention of left ventricular mural thrombosis in acute transmural anterior myocardial infarction: a double blind trial comparing high dose with low dose subcutaneous calcium heparin. N Engl Med J 1989; 320: 352-7.
41. Kontny F, Dale J, Abildgaard U, Hegrenaes L, Lern P, Morstol T. Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin. Eur Heart 3 1993; 14: 1040-3.
42. ASPECT Study Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499-503.
43. Ebert RV. Anticoagulants in acute myocardial infarction. Results of a cooperative clinical trial. JAMA 1973; 225: 724-29.
44. Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council : assessment of short-term anticoagulant administration after cardiac infarction. BMJ 1969; 1: 335-42.
45. Cabin HS, Roberts WC. Left ventricular aneurysm, intraancurysmal thrombus, and systemic embolus in coronary artery disease. Chest 1980; 77: 586-90.
46. La Rovere MT, Pozzoli M, Traversi E, Opasich C, Specchia G. Exercise tolerance in patients with and without ventricular aneurysm. Cardiology 1987; 74: 483-9.
47. Sherman DG, Dyken ML, Fisher M, Harrison MJG, Hart RG. Antithrombotic therapy for cerebrovascular disorders. Chest 1990; 95 (suppl): 140S-155S.
48. Simpson MT, Oberman A, Kouchoukos NT, Rogers WJ. Prevalance of mural thrombi and systemic embolization with left ventricular aneurysm: effect of anticoagulation therapy. Chest 1980; 77: 463-9.
49. Johannessen KA, Nordrchaug JE, Lippe GVD. Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction. Circulation 1987; 75: 151-5.
50. Harvey WP, Finch C. Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. N Engl J Med 1950; 242: 208-11.
51. Anderson GM, Hull E. Use of dicumarol as adjunct to treatment of congestive heart failure: results in controlled series of 61 cases. South Med J 1948; 41: 365-71.
52. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN. Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87 (suppl 6): VI94-101.
53. Atrial fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic treatment in atrial fibrillation: analysis of pooled data from randomized controlled trials. Arch Intern Med 1994; 154: 1449-57.
54. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992; 116: 1-5.
55. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992; 116: 6-12.